Effect of UTT on viral suppression and ART adherence

Affiliations

¹ Division of Global HIV/AIDS and TB, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. Electronic address: dtt6@cdc.gov.
² Division of Global HIV/AIDS and TB, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.

Comment

Pamela Bachanas et al. Lancet HIV. 2022 Nov.

. 2022 Nov;9(11):e738-e739.

doi: 10.1016/S2352-3018(22)00300-9.

¹ Division of Global HIV/AIDS and TB, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. Electronic address: dtt6@cdc.gov.
² Division of Global HIV/AIDS and TB, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.

No abstract available

Conflict of interest statement

We declare no competing interests.

Viral suppression and self-reported ART adherence after 3 years of universal testing and treatment in the HPTN 071 (PopART) community-randomised trial in Zambia and South Africa: a cross-sectional analysis.
Macleod D, Shanaube K, Skalland T, Limbada M, Mandla N, Bwalya J, Schaap A, Yang B, Donnell D, Piwowar-Manning E, Eshleman SH, Hoddinott G, Bond V, Moore A, Griffith S, Bock P, Ayles H, Fidler S, Hayes R, Floyd S; HPTN 071 (PopART) Study Team. Macleod D, et al. Lancet HIV. 2022 Nov;9(11):e751-e759. doi: 10.1016/S2352-3018(22)00237-5. Lancet HIV. 2022. PMID: 36332652 Free PMC article. Clinical Trial.